Method of lowering intraocular pressure with antazoline
US4097577A · kind A · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 1976 |
| Grant date | Jun 27, 1978 |
| Priority date | — |
| Expiry date | Aug 12, 1996 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/415
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for lowering intraocular pressure in mammals by administering thereto an effective amount of antazoline, i.e., 2-(N-benzylanilinomethyl)-2-imidazoline or its pharmacologically acceptable acid addition salts, preferably antazoline phosphate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.